<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dong Z</submitter><funding>Health and Medical Research Fund</funding><funding>NHGRI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1225-1233</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8522200</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(7)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Absence of heterozygosity (AOH) is a genetic characteristic known to cause human genetic disorders through autosomal recessive or imprinting mechanisms. However, the analysis of AOH via low-pass genome sequencing (GS) is not yet clinically available.&lt;h4>Methods&lt;/h4>Low-pass GS (fourfold) with different types of libraries was performed on 17 clinical samples with previously ascertained AOH by chromosomal microarray analysis (CMA). In addition, AOH detection was performed with low-pass GS data in 1,639 cases that had both GS and high-probe density CMA data available from the 1000 Genomes Project. Cases with multiple AOHs (coefficient of inbreeding F ≥ 1/32) or terminal AOHs ≥5 Mb (suspected uniparental disomy [UPD]) were reported based on the guidelines of the American Colleg</pubmed_abstract><journal>Genetics in medicine : official journal of the American College of Medical Genetics</journal><pubmed_title>Low-pass genome sequencing-based detection of absence of heterozygosity: validation in clinical cytogenetics.</pubmed_title><pmcid>PMC8522200</pmcid><funding_grant_id>04152666</funding_grant_id><funding_grant_id>UM1 HG008901</funding_grant_id><funding_grant_id>P01 GM061354</funding_grant_id><funding_grant_id>T32 GM007748</funding_grant_id><pubmed_authors>Choy KW</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Morton CC</pubmed_authors><pubmed_authors>Shi M</pubmed_authors><pubmed_authors>Leung TY</pubmed_authors><pubmed_authors>Chau MHK</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Dong Z</pubmed_authors><pubmed_authors>Wah YM</pubmed_authors><pubmed_authors>Kwok YK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Low-pass genome sequencing-based detection of absence of heterozygosity: validation in clinical cytogenetics.</name><description>&lt;h4>Purpose&lt;/h4>Absence of heterozygosity (AOH) is a genetic characteristic known to cause human genetic disorders through autosomal recessive or imprinting mechanisms. However, the analysis of AOH via low-pass genome sequencing (GS) is not yet clinically available.&lt;h4>Methods&lt;/h4>Low-pass GS (fourfold) with different types of libraries was performed on 17 clinical samples with previously ascertained AOH by chromosomal microarray analysis (CMA). In addition, AOH detection was performed with low-pass GS data in 1,639 cases that had both GS and high-probe density CMA data available from the 1000 Genomes Project. Cases with multiple AOHs (coefficient of inbreeding F ≥ 1/32) or terminal AOHs ≥5 Mb (suspected uniparental disomy [UPD]) were reported based on the guidelines of the American Colleg</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-05-28T07:08:41.667Z</modification><creation>2025-04-19T08:23:57.545Z</creation></dates><accession>S-EPMC8522200</accession><cross_references><pubmed>33772221</pubmed><doi>10.1038/s41436-021-01128-7</doi></cross_references></HashMap>